These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16972907)

  • 21. Fetal growth restriction is associated with reduced FasL expression by decidual cells.
    Eide IP; Isaksen CV; Salvesen KA; Langaas M; Günther CC; Iversen AC; Austgulen R
    J Reprod Immunol; 2007 Jun; 74(1-2):7-14. PubMed ID: 17196256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of specific antisense oligonucleotide inhibition of Fas expression on T cell apoptosis induced by Fas ligand.
    Mao H; Liu Q; Zhang J; Gu H; Wang L; Zhou X; Yin H; Zhang L; Xie F; Jiang G
    Int Immunopharmacol; 2007 Dec; 7(13):1714-22. PubMed ID: 17996681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment.
    Fernández M; Segura MF; Solé C; Colino A; Comella JX; Ceña V
    J Neurochem; 2007 Oct; 103(1):190-203. PubMed ID: 17635665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of FasL-induced apoptosis in immune privilege.
    Griffith TS; Ferguson TA
    Immunol Today; 1997 May; 18(5):240-4. PubMed ID: 9153956
    [No Abstract]   [Full Text] [Related]  

  • 25. Placental fas/fas ligand expression in early pregnancy losses.
    Guvendag Guven ES; Okur H; Beksac MS
    Am J Reprod Immunol; 2008 Jul; 60(1):1-7. PubMed ID: 18422813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of FasL on inflammation and tumor survival are dependent on its expression levels.
    Wada A; Tada Y; Kawamura K; Takiguchi Y; Tatsumi K; Kuriyama T; Takenouchi T; O-Wang J; Tagawa M
    Cancer Gene Ther; 2007 Mar; 14(3):262-7. PubMed ID: 17053813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A historical perspective on immunological privilege.
    Simpson E
    Immunol Rev; 2006 Oct; 213():12-22. PubMed ID: 16972893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fas ligand as a tool for immunosuppression and generation of immune tolerance.
    Bohana-Kashtan O; Civin CI
    Stem Cells; 2004; 22(6):908-24. PubMed ID: 15536183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coelomic cells show apoptosis via Fas/FasL system: a comparative study between healthy human pregnancies and missed miscarriages.
    Kaponis A; Skyrlas A; Zagorianakou N; Georgiou I; Passa V; Paraskevaidis E; Makrydimas G
    Hum Reprod; 2008 May; 23(5):1159-69. PubMed ID: 18316328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caspase-8- and JNK-dependent AP-1 activation is required for Fas ligand-induced IL-8 production.
    Matsumoto N; Imamura R; Suda T
    FEBS J; 2007 May; 274(9):2376-84. PubMed ID: 17403042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand.
    Gregory MS; Saff RR; Marshak-Rothstein A; Ksander BR
    Cancer Res; 2007 Dec; 67(24):11951-8. PubMed ID: 18089826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The testis in immune privilege.
    Fijak M; Meinhardt A
    Immunol Rev; 2006 Oct; 213():66-81. PubMed ID: 16972897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions.
    Pearl-Yafe M; Yolcu ES; Stein J; Kaplan O; Yaniv I; Shirwan H; Askenasy N
    Stem Cells; 2007 Jun; 25(6):1448-55. PubMed ID: 17363551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immune reactions in the eye].
    Esterre P; Auzemery A; Godinaud P
    Arch Inst Pasteur Madagascar; 1996; 63(1-2):19-23. PubMed ID: 12463010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of cell death ligand and receptor system on regulation of follicular atresia in pig ovaries.
    Manabe N; Matsuda-Minehata F; Goto Y; Maeda A; Cheng Y; Nakagawa S; Inoue N; Wongpanit K; Jin H; Gonda H; Li J
    Reprod Domest Anim; 2008 Jul; 43 Suppl 2():268-72. PubMed ID: 18638134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis signaling pathways and lymphocyte homeostasis.
    Xu G; Shi Y
    Cell Res; 2007 Sep; 17(9):759-71. PubMed ID: 17576411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability.
    Houston AM; Michael-Robinson JM; Walsh MD; Cummings MC; Ryan AE; Lincoln D; Pandeya N; Jass JR; Radford-Smith GL; O'Connell J
    Hum Pathol; 2008 Feb; 39(2):243-50. PubMed ID: 17961631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of FasL expression in tumor cells and preventing tumor necrosis factor-induced apoptosis by adenovirus 14.7K is an effective escape mechanism for immune cells.
    Zhang J; Xu G
    Cancer Genet Cytogenet; 2007 Dec; 179(2):112-7. PubMed ID: 18036397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
    Kassouf N; Thornhill MH
    Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway.
    Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L
    Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.